Clinical Trials
42 trialsMONITOR-UK
Royal Marsden NHS Foundation Trust
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
National Institutes of Health Clinical Center (CC)
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Cancer Trials Ireland
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
GREAT
ARCAGY/ GINECO GROUP
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
Mayo Clinic
GYM-TASTE
Ankara Etlik City Hospital
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Memorial Sloan Kettering Cancer Center
ROOT
Taproot Health
HITOMI
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
M.D. Anderson Cancer Center
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer
University of Minnesota
HALO
AstraZeneca
C-PATROL
AstraZeneca
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
OLALA
University Health Network, Toronto
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer
Memorial Sloan Kettering Cancer Center
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
NRG Oncology
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario
nCYT
Boston Scientific Corporation
Evaluation of Robot-Assisted Surgery in Gynecologic Oncology
M.D. Anderson Cancer Center
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
GOG Foundation
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
Abramson Cancer Center at Penn Medicine
BRCA
AstraZeneca
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
Memorial Sloan Kettering Cancer Center
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
Duke University
OVATAR
AstraZeneca
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Memorial Sloan Kettering Cancer Center
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
GOG Foundation
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
GOG Foundation
A Survivorship Care Plan for Gynaecological Cancer Patients
Royal Marsden NHS Foundation Trust
Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
Ain Shams University
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
National Cancer Institute (NCI)
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
Elizabeth Registry for Low Grade Ovarian Cancer
M.D. Anderson Cancer Center
Pharmacogenomics of Paclitaxel in Ovarian Cancer
University of Southern Denmark
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
University of California, San Francisco
Validation of a Nutrition Screening Tool
Royal Marsden NHS Foundation Trust
Pharmacogenomics of Paclitaxel in Ovarian Cancer
University of Southern Denmark
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
Precision Therapeutics